Key facts
- This page summarizes Marcus Schulz's Form 4 filing for BIOLIFE SOLUTIONS INC (BLFS).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 09 Jul 2021, 20:00.
Marcus Schulz - 08 Jul 2021 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)
- Reporting relationship
- Chief Revenue Officer
- Issuer ticker
- BLFS
- Reported as of
- 08 Jul 2021
- Net transaction value
- -$10,976
- SEC form
- 4
- Accepted by SEC
- 09 Jul 2021, 20:00:25 UTC
- Next SEC filing
- 22 Jul 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Marcus Schulz
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Marcus Schulz filed Form 4 for BIOLIFE SOLUTIONS INC (BLFS) on 09 Jul 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: -$10,976.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BLFS
transaction
Common Stock
Sale
- Transaction value
- $4,575
- Shares
- -100
- Change %
- -0.26%
- Price
- $45.75
- Shares after
- 39,045
- Date
- 08 Jul 2021
- Ownership
- Direct
- Footnotes
- F1
BLFS
transaction
Common Stock
Sale
- Transaction value
- $6,401
- Shares
- -140
- Change %
- -0.36%
- Price
- $45.72
- Shares after
- 38,905
- Date
- 08 Jul 2021
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The sales reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.